[Application of the artificial intelligence-rapid whole-genome sequencing diagnostic system in the neonatal/pediatric...

Area of Science:

• Genomics
• Medical Diagnostics
• Artificial Intelligence

Background:

• Neonatal intensive care unit (NICU) and pediatric intensive care unit (PICU) patients have a high incidence of genetic diseases.
• Early diagnosis and intervention are crucial for reducing mortality and improving outcomes in these pediatric populations.
• Current whole-genome sequencing methods are time-consuming and require extensive professional interpretation, delaying clinical application.

Purpose of the Study:

• To introduce the clinical application of rapid whole-genome sequencing in NICU/PICU settings.
• To describe artificial intelligence-based techniques for rapid whole-genome sequencing data analysis.
• To present a novel diagnostic system for timely genetic disease diagnosis in critically ill children.

Main Methods:

• Development of a rapid, high-throughput, automated platform for genetic disease diagnosis.
• Integration of artificial intelligence into the post-sequencing data processing pipeline.
• Focus on whole-genome sequencing to capture diverse genetic variations (point mutations, copy number, structural variations).

Main Results:

• The AI-driven system significantly reduces diagnostic time for genetic diseases.
• Provides a rapid diagnostic regimen for critically ill children within 24 hours.
• Addresses the limitations of long turnaround times and extensive interpretation needs of traditional sequencing.

Conclusions:

• Rapid whole-genome sequencing, powered by AI, offers a promising solution for diagnosing genetic diseases in NICU/PICU patients.
• The AI-rapid whole-genome sequencing diagnostic system can expedite etiological diagnosis and targeted interventions.
• This technology holds significant potential for improving clinical management and patient outcomes in critically ill children.